France, Nov. 7 -- Tunisia's migration policy is under scrutiny two years on from a deal with the European Union intended to discourage illegal migration from the North African country, and from a "rep... Read More
India, Nov. 7 -- If you have been waking up to endless headlines about Lily Allen, her relationships and other controversial details from her dating history these past few days, you're definitely not ... Read More
Mumbai, Nov. 7 -- The stock was listed at Rs 570, reflecting a discount of 2.56% to the issue price. So far, the stock has hit a high of 585 and a low of 555.80. On the BSE, over 4.13 lakh shares of ... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225439) titled 'Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relap... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225595) titled 'Shifting Options Study' on Nov. 19, 2024. Brief Summary: The goal of Shifting Options is to... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225608) titled 'The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Ener... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225426) titled 'Personalizing Financial Incentives' on Nov. 04. Brief Summary: The purpose of this study is... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225530) titled 'Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)' ... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225244) titled 'Comparative Outcomes of Four Versus Two Balloon Inflation Points in Dacryoplasty for Primary... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225543) titled '2-HOBA in Systemic Lupus Erythematosus' on Nov. 04. Brief Summary: This is a phase II rando... Read More